Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 3608-3612, July 1, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raymond, V. W.
Right arrow Articles by Shelton Earp, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raymond, V. W.
Right arrow Articles by Shelton Earp, H.

Regulation of Transforming Growth Factor {alpha} Messenger RNA Expression in a Chemically Transformed Rat Hepatic Epithelial Cell Line by Phorbol Ester and Hormones1

Victoria W. Raymond2, David C. Lee, Joe W. Grisham and H. Shelton Earp

Lineberger Cancer Research Center, Cell Biology Program [V. W. R., D. C. L., J. W. G., H. S. E.], Department of Microbiology and Immunology [D. C. L.], Pathology [J. W. G.], Medicine [H. S. E.], and Pharmacology, [H. S. E.], The University of North Carolina, Chapel Hill, North Carolina 27599

Transforming growth factor {alpha} (TGF-{alpha}) is produced by many transformed cells, but little is known about the regulation of its expression. We examined TGF-{alpha} mRNA levels in a set of cloned neoplastic cell lines derived by chemical transformation of a normal rat liver epithelial cell. The untransformed parental cell line, WB-344, did not express a detectable level of TGF-{alpha} mRNA, whereas GP6ac, a transformed line capable of autonomous growth in soft agar, expressed TGF-{alpha}. When GP6ac cells were treated with agents thought to regulate protein kinase C activity, e.g., the tumor promoter, 12-O-tetradecanoylphorbol-13-acetate (TPA), TGF-{alpha} mRNA levels increased by 8- to 11-fold. The induction of TGF-{alpha} mRNA was detectable at 2 h, was maximal at 8–12 h, and declined by 24 h. Angiotensin, bradykinin, epinephrine, and epidermal growth factor also increased TGF-{alpha} mRNA by 2- to 5-fold. In contrast, parental WB cells neither expressed TGF-{alpha} mRNA, nor responded to TPA. TPA also increased epidermal growth factor receptor mRNA in GP6ac cells but the effect was less prolonged; maximal levels were seen at 4 h after TPA exposure and returned to control levels by 12 h.

TPA increased TGF-{alpha} mRNA in GP6ac cells, in part, by increasing transcription of the TGF-{alpha} gene as measured by run-on transcription rates in isolated nuclei. In addition, the induction of TGF-{alpha} by TPA was blocked by concurrent incubation with agents that inhibit protein synthesis. However, if TPA was present for at least 2 h, subsequent addition of cycloheximide enhanced the effect of TPA. This indicates that the induction of TGF-{alpha} in GP6ac cells is comprised of at least two phases demarcated by the requirement for protein synthesis. The time course of induction and the sensitivity to inhibition of protein synthesis distinguish the effect of TPA on TGF-{alpha} mRNA from that of other genes regulated by TPA, e.g., c-myc and c-fos. These data also suggest that chemical transformation of rat liver epithelial cells leads to expression of TGF-{alpha} mRNA, and that once expressed, TGF-{alpha} mRNA can be modulated in a protein kinase C-dependent manner.

1 This work was supported by NIH Grants CA-43793 (D. C. L.), CA-29323 (J. W. G.), and DK-30002 (H. S. E.).

2 Supported by NIH postdoctoral training Grant CA-09156-11. To whom requests for reprints should be addressed, at Lineberger Cancer Research Center, CB 7295, University of North Carolina, Chapel Hill, NC 27599.

Received 10/28/88. Revised 3/27/89. Accepted 3/31/89.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
M. Kagawa, T. Sano, N. Ishibashi, M. Hashimoto, M. Okuno, H. Moriwaki, R. Suzuki, H. Kohno, and T. Tanaka
An acyclic retinoid, NIK-333, inhibits N-diethylnitrosamine-induced rat hepatocarcinogenesis through suppression of TGF-{alpha} expression and cell proliferation
Carcinogenesis, June 1, 2004; 25(6): 979 - 985.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Wrischer
An in vitro model of the early genetic events in multistage carcinogenesis of malignant insulinoma
Carcinogenesis, August 1, 1999; 20(8): 1521 - 1528.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.